|
|
|
|
|
|
NOVANTRONE is indicated for reducing neurologic disability and/or the frequency of clinical relapses in patients with secondary progressive, progressive relapsing and worsening relapsing-remitting MS.
NOVANTRONE is not indicated for primary progressive MS. Novantrone is not recommended for MS patients with a certain blood cell count, liver function test, or cardiac abnormalities; or for women who plan to become or are pregnant. See Novantrone Prescribing Information for full disclosure of important safety information, including dosing and administration precautions.
|
|
|
